Protein drug stability: a formulation challenge (Q36085672)

12 August 2017

1 reference

title

Protein drug stability: a formulation challenge (English)

1 reference

12 August 2017

Daniel E Otzen

2

0 references

author name string

Sven Frokjaer

series ordinal

1

1 reference

12 August 2017

publication date

1 April 2005

1 reference

Nature Reviews Drug Discovery

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

298-306

1 reference

Chemical space and biology

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Recombinant protein therapeutics--success rates, market trends and values to 2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

The stability factor: importance in formulation development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Instability, stabilization, and formulation of liquid protein pharmaceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Structure-immunogenicity relationships of therapeutic proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Absorption enhancers in pulmonary protein delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Monomeric insulins and their experimental and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Peginterferon alfa-2a: a review of approved and investigational uses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

The role of branched polyesters and their modifications in the development of modern drug delivery vehicles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Smart and genetically engineered biomaterials and drug delivery systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Nanotechnological approaches for the delivery of macromolecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Hydrogels in pharmaceutical formulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

In situ forming parenteral drug delivery systems: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Liposomes for intravenous drug targeting: design and applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Nanostructured lipid matrices for improved microencapsulation of drugs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Parenteral water/oil emulsions containing hydrophilic compounds with enhanced in vivo retention: formulation, rheological characterisation and study of in vivo fate using whole body gamma-scintigraphy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Association of acylated cationic decapeptides with dipalmitoylphosphatidylserine-dipalmitoylphosphatidylcholine lipid membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Antibodies against rHuEPO: native and recombinant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Probing structural changes of proteins incorporated into water-in-oil emulsions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein aggregation and its inhibition in biopharmaceutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein aggregation: folding aggregates, inclusion bodies and amyloid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein folding at the air-water interface studied with x-ray reflectivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Modulation of S6 fibrillation by unfolding rates and gatekeeper residues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Inverse relationship of protein concentration and aggregation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Oxidative renaturation of lysozyme at high concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Stressed-out B cells? Plasma-cell differentiation and the unfolded protein response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A trip to the ER: coping with stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Macromolecular crowding: an important but neglected aspect of the intracellular environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Influence of excluded volume upon macromolecular structure and associations in 'crowded' media

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Role of Escherichia coli curli operons in directing amyloid fiber formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Pathological and functional amyloid formation orchestrated by the secretory pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein misfolding, evolution and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A 50th order reaction predicted and observed for sickle hemoglobin nucleation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Simulations of kinetically irreversible protein aggregate structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Lattice simulations of aggregation funnels for protein folding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Analysis of protein aggregation kinetics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein folding in the cell: reshaping the folding funnel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Kinetic partitioning of protein folding and aggregation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Role for the alpha-helix in aberrant protein aggregation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Rationalization of the effects of mutations on peptide and protein aggregation rates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Probing the mechanism of insulin fibril formation with insulin mutants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: A structural clue to amyloid assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Salt-induced detour through compact regions of the protein folding landscape

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Designing drugs to stop the formation of prion aggregates and other amyloids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Observation of sequence specificity in the seeding of protein amyloid fibrils.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Stereospecific amyloid-like fibril formation by a peptide fragment of beta2-microglobulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Seeding specificity in amyloid growth induced by heterologous fibrils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Direct measurement of the thermodynamic parameters of amyloid formation by isothermal titration calorimetry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Amyloid fibers are water-filled nanotubes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Structural basis of protein kinetic stability: resistance to sodium dodecyl sulfate suggests a central role for rigidity and a bias toward beta-sheet structure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Why are enzymes less active in organic solvents than in water?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Kinetic stabilization of Bacillus licheniformis alpha-amylase through introduction of hydrophobic residues at the surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Peptide aggregation in neurodegenerative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Challenges in the development of high protein concentration formulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein hydration, thermodynamic binding, and preferential hydration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

How Hofmeister ion interactions affect protein stability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Inhibition of aggregation side reactions during in vitro protein folding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A simple method for improving protein solubility and long-term stability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protection of bovine serum albumin from aggregation by Tween 80.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Artificial chaperone-assisted refolding of carbonic anhydrase B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Formation of amyloid fibers triggered by phosphatidylserine-containing membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Phospholipid catalysis of diabetic amyloid assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Evidence for an intermediate in tau filament formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and (1)H NMR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Structural basis for cyclodextrins' suppression of human growth hormone aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Influence of cyclodextrin ring substituents on folding-related aggregation of bovine carbonic anhydrase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Structural background of cyclodextrin-protein interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

A simple way to measure protein refolding rates in water

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Cyclodextrins as protein folding aids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Lyophilization and development of solid protein pharmaceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Freeze-drying of bioproducts: putting principles into practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Long-term stabilization of biologicals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Moisture-induced aggregation of lyophilized insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

On the relationship between conformation and stability in solid pharmaceutical protein formulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Toward understanding insulin fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Dityrosine as a product of oxidative stress and fluorescent probe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein folding and misfolding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

Protein destabilization at low temperatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1695

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD1695

1 reference

Dimensions Publication ID

12 August 2017

1019770135

0 references

1 reference